Dupert offers new hope for advanced NSCLC patients as China’s first KRAS G12C Inhibitor: GlobalData Read more
China’s Innovent holds potential to change pancreatic cancer treatment with bispecific antibody IBI389: GlobalData Read more
US FDA grants Orphan Drug Designation to BCMA CAR-T cell therapy co-developed by Innovent Biologics and IASO Bio Read more
Innovent and Eli Lilly announce final clinical results and biomarker analysis of phase-Ib study of Sintilimab injection plus Bevacizumab biosimilar injection Read more